caret icon Back to all discussions

Me and my Organoid

Human clinical trials are an expensive component of the drug discovery pathway, which often fail due to the fundamental differences between humans and animal model physiology.

But now with organoids, scientists can screen multiple therapies at once, streamlining that process and helping to reduce the number of animals used for research. New compounds or combinations of drugs can be tested on human organoids earlier, discarding unsafe, ineffective or toxic drugs immediately. In turn this helps speed up new drug discoveries and reduce the overall costs of medicines.

As organoids are similar to original organs, scientists use them to study organ development and diseases. These mini-organs can be stored in biobanks and can be used for scientific research, drug screening, disease modeling, precision medicine and regenerative medicine.

  1. Hi again, @kerrysworld (nobody special), and thanks for your post. I agree with your point that the condition is a one-size fits all condition

    My experience is that COPD/asthma affects each individual differently. As well, the treatment for each person, diagnosed with the condition, can vary considerably. Taking it even one step further, I've found that the efficacy of medications can also be quite different from patient to patient. The physicians who I work with have treated patients as individuals and treated their illnesses, which can be unique, for each patient, accordingly.

    We have an article published, right here on our website, that underscores this very point of view. For your convenience, here is a link to that article:

    I do hope you find it bot helpful and interesting to read.

    Wishing you well,
    Leon (site moderator

    1. This is where funding should be applied. We are all different so what works or doesn't work for you may or may not work for me and vise-versa.

      Currently pulmonary care is a one size fits all application. It should not be.

      or create an account to reply.